NYSE$TDOC

Teladoc Health Inc · Q2 2024 earnings

Q2 2024 earnings · · Investor relations

Briefing

Teladoc Health's Q2 2024 results were impacted by BetterHelp headwinds, while Integrated Care showed solid performance.

Teladoc Health reported a 2% year-over-year decrease in revenue to $642.4 million for Q2 2024. The company experienced a net loss of $837.7 million, which includes a goodwill impairment charge of $790.0 million. While the Integrated Care segment performed well, the BetterHelp segment faced continued headwinds.

  • Revenue decreased by 2% year-over-year to $642.4 million.
  • Net loss totaled $837.7 million, including a $790.0 million goodwill impairment charge.
  • Adjusted EBITDA increased by 24% year-over-year to $89.5 million.
  • Integrated Care revenue increased by 5% year-over-year, while BetterHelp revenue decreased by 9%.

Headline financials

Total Revenue

$642M

Previous: $652M-1.5%
EPS (adj)

-$0.28

Previous: -$0.40+30.0%
Capital Expenditures

-$3.06M

Previous: -$4.27M+28.3%
Free Cash Flow

-$841M

Previous: -$69.4M-1110.7%
Net Income

-$838M

Previous: -$65.2M-1185.2%
Operating Income

-$841M

Previous: -$71.6M-1074.0%
Gross Profit

-$188M

Previous: $462M-140.7%
Cash & Equivalents

$1.16B

Previous: $959M+21.2%
Total Assets

$3.52B

Previous: $4.32B-18.4%
R&D Expense

$76.8M

No prior period
Stock-Based Comp

$42.1M

Previous: $55.7M-24.4%

Revenue & EPS history

Teladoc · Revenue · Quarterly

$642M

Q2 2024-1.5%vs Q2 2023
Beat estimate in 9 of 15 quarters(60%)
ActualEstimate

Revenue by segment

Teladoc · $660M total across 2 segments · Q3 2023

  • Integrated Care
    $374M
  • BetterHelp
    $286M

Forward guidance

Teladoc Health is withdrawing the financial outlook for the Full Year of 2024 for its Consolidated operations and its BetterHelp segment. For the third quarter of 2024, we expect Integrated Care Revenue growth percentage (year-over-year) 1% - 2% and Adjusted EBITDA margin 14.5% - 16.0%.

Tailwinds

  • Integrated Care segment revenue growth is expected to be 1%-2% year-over-year for Q3 2024.
  • Integrated Care segment Adjusted EBITDA margin is expected to be 14.5%-16.0% for Q3 2024.
  • Integrated care members are expected to be between 92.5 - 93.5 million for Q3 2024.
  • Integrated Care segment revenue growth is expected to be low single digits to mid-single digits for full year 2024.
  • Integrated Care adjusted EBITDA margin expansion (year-over-year) +150bps to +200bps for full year 2024

Headwinds

  • Financial outlook for the Full Year of 2024 for its Consolidated operations has been withdrawn.
  • Financial outlook for the BetterHelp segment has been withdrawn.
  • Three year outlook on its Consolidated operations has been withdrawn.
  • Three year outlook on its operating segments has been withdrawn.
  • The company is facing headwinds in the BetterHelp segment.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q2 2024

Historical avgQ2 2024

-1.2%

Avg return

Earnings day

-2.1%

Avg return

5 days after

-1.6%

Avg return

30 days after

49%

21 / 43 earnings

Positive

+23.7%

Q2 2023

Best reaction

-42.0%

Q1 2022

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+1.8%+11.9%+27.9%
Q4 2025+15.5%+9.7%+10.5%
Q3 2025+6.2%-3.0%-7.8%
Q1 2025-2.8%-5.7%-3.8%
Q4 2024-13.6%-16.3%-26.4%
Q3 2024+0.9%-0.6%+34.3%
Q2 2024-11.7%-21.9%-26.3%
Q1 2024-5.2%-7.1%-16.4%
Q4 2023-25.6%-31.1%-27.3%
Q3 2023-3.3%-13.5%-5.3%
Q2 2023+23.7%+20.9%-6.1%
Q1 2023+3.4%+2.2%-14.4%
Q4 2022-3.9%-5.4%-12.2%
Q3 2022+6.4%+10.8%+3.2%
Q2 2022-11.4%-8.4%-20.1%
Q1 2022-42.0%-35.7%-38.1%
Q4 2021-5.4%+8.8%+6.8%
Q3 2021+5.6%+7.2%-22.4%
Q2 2021+1.4%-0.9%-5.5%
Q1 2021-10.1%-14.1%-20.7%
Q4 2020-14.2%-12.7%-30.9%
Q3 2020-2.3%-14.6%-11.9%
Q2 2020+11.5%+11.5%-1.9%
Q1 2020-9.1%-3.8%-3.9%
Q4 2019+14.1%+5.1%+38.6%
Q3 2019+7.1%+12.3%+17.1%
Q2 2019+1.9%-6.5%-17.5%
Q1 2019-2.0%+2.9%-1.8%
Q4 2018-4.5%-6.3%-17.5%
Q3 2018+4.6%-8.6%-9.9%
Q2 2018+9.0%+10.3%+29.6%
Q1 2018+5.7%-1.9%+18.4%
Q4 2017+4.0%+8.8%+4.5%
Q3 2017-3.0%-5.4%+8.0%
Q2 2017-7.1%-2.6%+5.5%
Q1 2017+23.3%+26.9%+46.3%
Q4 2016+6.8%-4.8%+13.4%
Q3 2016+6.2%+8.6%+19.4%
Q2 2016-16.1%-9.0%+2.9%
Q1 2016-1.5%
Q4 2015-7.3%
Q3 2015-10.6%
Q2 2015+3.6%
Q1 2015
Q4 2014
Q3 2014
Q2 2014
Q1 2014

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro